Life Sciences Masters™ 2025 IPW Studios, Ashburn, VA
October 27 - 29, 2025
Hero background

Event Session

The Truth About Pharma Patent Practices: Separating Fact and Fiction *

October 27, 2025 @ 11:50 AM EST

11:50 AM ET
October 27, 2025

The Truth About Pharma Patent Practices: Separating Fact and Fiction *

View Session Speakers

CLEIn the ongoing debate over prescription drug prices, the role of patents is often misunderstood—and sometimes deliberately misrepresented. This panel will present the perspective of brand-name pharmaceutical companies, exploring how patents support medical innovation, sustain research investment, and enable life-saving breakthroughs.

Panelists will address the myths and misinformation spread by patent critics—including the repeated distortions from organizations like I-MAK—and will walk through the real data behind drug patent portfolios. Attendees will gain a clear, fact-based understanding of how the patent system actually functions in the pharmaceutical sector, why “evergreening” is often mischaracterized, and how responsible IP strategies drive both innovation and patient access.

Materials:

Counting Patents, Not Progress: Another Misdiagnosis by I-MAK

Amgen Attacks Academics’ False Claims About Biologic Patents

Setting the Record Straight: The Truth about Patents in the Biopharmaceutical Sector

Debunked: USPTO Findings Should End False Pharma Patent Narratives

Facts, Not False Political Narratives, Should Drive American Competitiveness

SURVEY:

https://www.surveymonkey.com/r/The-Truth-About-Pharma-Patent-Practices



Add to Calendar 06/09/2026 5:09 PM America/New_York The Truth About Pharma Patent Practices: Separating Fact and Fiction *

In the ongoing debate over prescription drug prices, the role of patents is often misunderstood—and sometimes deliberately misrepresented. This panel will present the perspective of brand-name pharmaceutical companies, exploring how patents support medical innovation, sustain research investment, and enable life-saving breakthroughs. Panelists will address the myths and misinformation spread by patent critics—including the repeated distortions from organizations like I-MAK—and will…

Session Speakers

Christian Bauer

Fractional In-House IP Counsel

Multiple Biotech Companies

Paul Higgins

Vice President of Law - Head of Global IP Policy

Johnson & Johnson

Emily Johnson

Head of Global Intellectual Property Policy, Innovation Law

Bristol Myers Squibb

Joshua Kresh

Research Professor, Executive Director

The IP Policy Institute, The University of Akron School of Law

Chief Judge Paul Michel

Hon. Paul R. Michel

Chief Judge (ret.)

US Court of Appeals for the Federal Circuit